Home treatment of cytomegalovirus retinitis with intravenous Ganciclovir.

Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party

“… infections in cystic fibrosis [8–10]; chronic bone and prosthetic joint infections [11–14]; ‘low‐risk’ neutropenic fevers [15–20]; cytomegalovirus (CMV) infection in immuno‐compromised hosts [21–23]; skin and soft tissue infections not amenable to oral therapy [24,25]. …”

“…1. CMV retinitis, which mainly occurs in patients with AIDS, initially required induction and then lifelong maintenance therapy with intravenous ganciclovir or foscarnet [21,22]. This is best achieved in an outpatient setting, largely because of the indefinite duration of therapy.…”

Intravenous antimicrobial therapy in the community: underused, inadequately resourced, or irrelevant to health care in Britain?

“…Despite these reservations there is growing experience in Britain of community intravenous therapy for recurrent infections in patients with cystic fibrosis15 and cancer,16 for chronic orthopaedic infections such as osteomyelitis and septic arthritis,17 and for infections complicating AIDS 18…”